» Articles » PMID: 6249436

A Classification of Opiate Receptors That Mediate Antinociception in Animals

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1980 Jul 1
PMID 6249436
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

1 To investigate the opiate receptors that mediate antinociception, the activity profiles of opioid analgesic drugs have been determined against different nociceptive stimuli in the mouse and rat. 2 In tests that employ heat as the nociceptive stimulus, mu-opiate receptor agonists, such as morphine, pethidine and dextropropoxyphene, had steep and parallel dose-response curves and were capable of achieving maximum effects. In addition, the antinociceptive potency ratios of these drugs in heat tests were similar to those for analgesia in man. 3 The kappa-agonists, such as ethylketazocine, nalorphine, Mr2034 and pentazocine, were essentially inactive against heat nociception except at doses that caused sedation and motor incapacitation. 4 In the writhing and paw pressure tests both mu- and kappa-agonists produced steep and parallel dose-response curves. 5 It is concluded that both mu- and kappa-opiate receptors mediate antinociception in animals and that the interactions of analgesic drugs with these receptors may be classified in terms of their antinociceptive activities against qualitatively different nociceptive stimuli.

Citing Articles

NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties.

Huang P, Ho C, Cao D, Inan S, Rawls S, Li M J Pharmacol Exp Ther. 2024; 389(1):106-117.

PMID: 38409113 PMC: 10949162. DOI: 10.1124/jpet.123.001870.


Signaling underlying kappa opioid receptor-mediated behaviors in rodents.

Liu-Chen L, Huang P Front Neurosci. 2022; 16:964724.

PMID: 36408401 PMC: 9670127. DOI: 10.3389/fnins.2022.964724.


Measuring Mouse Somatosensory Reflexive Behaviors with High-speed Videography, Statistical Modeling, and Machine Learning.

Abdus-Saboor I, Luo W Neuromethods. 2022; 178:441-456.

PMID: 35783537 PMC: 9249079. DOI: 10.1007/978-1-0716-2039-7_21.


Antinociceptive Effects of Kappa-Opioid Receptor Agonists.

Lazenka M Handb Exp Pharmacol. 2021; 271:293-313.

PMID: 33387069 DOI: 10.1007/164_2020_430.


Zerumbone-Induced Analgesia Modulated via Potassium Channels and Opioid Receptors in Chronic Constriction Injury-Induced Neuropathic Pain.

Gopalsamy B, Chia J, Farouk A, Sulaiman M, Perimal E Molecules. 2020; 25(17).

PMID: 32858809 PMC: 7503342. DOI: 10.3390/molecules25173880.


References
1.
Pearl J, Harris L . Inhibition of writhing by narcotic antagonists. J Pharmacol Exp Ther. 1966; 154(2):319-23. View

2.
GRAY W, Osterberg A, Scuto T . Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method. J Pharmacol Exp Ther. 1970; 172(1):154-62. View

3.
OCallaghan J, Holtzman S . Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther. 1975; 192(3):497-505. View

4.
Hughes J, KOSTERLITZ H, Leslie F . Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol. 1975; 53(3):371-81. PMC: 1666422. DOI: 10.1111/j.1476-5381.1975.tb07373.x. View

5.
Hutchinson M, KOSTERLITZ H, Leslie F, Waterfield A . Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br J Pharmacol. 1975; 55(4):541-6. PMC: 1666732. DOI: 10.1111/j.1476-5381.1975.tb07430.x. View